Dental Innovation Alliance VC Fund I, LP has made a strategic investment in SJC Bio, Inc. to support the development of OsseoCem, a rapid-setting bone graft cement designed to significantly reduce healing time in dental implant procedures.

Information on the target

Dental Innovation Alliance VC Fund I, LP (DIA) has made a strategic investment in SJC Bio, Inc., a pioneering biomaterials company focused on revolutionizing dental implant procedures. SJC Bio is developing OsseoCem, a rapid-setting, load-bearing bone graft cement that allows for the immediate placement of permanent crowns on dental implants. This innovation significantly reduces the traditional healing time from months to mere minutes, thereby enhancing patient satisfaction and practice efficiency.

With approximately 5 million dental implants placed annually in the United States, the existing standard of care necessitates a healing period of three to six months, often requiring multiple patient visits. SJC Bio's OsseoCem addresses this critical challenge by providing immediate load-bearing stability at the time of implant placement, allowing for a streamlined process that transforms the multi-visit experience into a single appointment.

Industry overview in the target’s specific country

The dental industry in the United States is a robust sector valued at approximately $450 billion, characterized by continuous innovation and advancements in technology. With a growing population and increasing awareness of oral health, th